Home / Clinical Decision Support & Reference / Ethos Treatment Management (3.0)

Ethos Treatment Management (3.0)

by Varian Medical Systems · Based in United States → — An Adaptive Intelligence solution for personalized radiation therapy.

Oncology Radiology

Website

Claim this tool

Is this the maker? Claim the company →

Leave this field empty

Correct company / maker

Company website (optional)

Anything else? (optional)

Contact vendor for pricing.

Regulatory Status Disclosed

Overview

Ethos Treatment Management (3.0) by Varian Medical Systems is an artificial intelligence (AI)-driven adaptive radiotherapy system designed to optimize treatment planning and delivery for cancer patients. It leverages AI to adjust treatment plans daily, in real-time, based on changes in the patient’s anatomy, such as tumor shrinkage or organ movement. This allows for more precise and personalized cancer treatment, targeting tumors more accurately while protecting surrounding healthy tissues. The system integrates advanced imaging capabilities, including HyperSight imaging, and AI-enhanced segmentation to streamline workflows and facilitate direct dose calculation for adapting treatments. Ethos aims to increase the capability, flexibility, and efficiency of radiotherapy, enabling the delivery of an entire adaptive treatment within a typical 15-minute timeslot, from patient setup through treatment delivery.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

AI-driven adaptive radiotherapy
Daily treatment plan adaptation based on anatomical changes
Real-time anatomy mapping and tumor targeting
Semi-automated and AI-supported treatment planning
HyperSight imaging for enhanced visualization and direct dose calculation
AI-enhanced image segmentation (auto-contouring of 70+ anatomical structures)
Optimized clinical and operational efficiencies with ARIA Coexistence
Flexible treatment techniques: adaptive, IGRT, IMRT, VMAT, SBRT
Automated dose accumulation and forecasting
Fast treatment sessions (e.g., 15 minutes)

Use Cases

Treating various cancers (prostate, lung, bladder, gynecologic, anal, breast, head and neck, kidney, liver, oligometastatic, pancreatic cancers)
Personalized radiation therapy for cancer patients
Adaptive radiation therapy for tumors that shift in location or size
Streamlining clinical workflows in radiation oncology departments
Optimizing radiation treatment planning and delivery
Managing and monitoring radiation therapy treatment plans and sessions

What Physicians Need to Know

Evidence Base

Ethos Treatment Management leverages AI-driven planning and contouring capabilities for adaptive radiation therapy. It utilizes multimodality images (MR, PET, CT) and daily iterative CBCT images to inform adaptive treatment decisions. The system aims to improve target coverage and reduce normal tissue exposure, with moderate quality evidence from observational studies demonstrating superior dosimetric benefits. An Adaptive Intelligence Consortium was established to conduct clinical trials and develop evidence-based clinical protocols for Ethos therapy. The efficacy of its Intelligent Optimization Engine (IOE) for auto-planning has been assessed in studies.

Clinical Validation Studies

Design verification and validation testing confirms that Ethos Treatment Management 3.0 and Ethos Treatment Planning 2.0 perform as intended and meet essential performance requirements. Software verification and validation testing was conducted in accordance with FDA Quality System Regulation. AI models used for organ detection via segmentation have validated characteristics, with static weights that do not continuously learn from user input. A dosimetric study successfully validated the accuracy of the Ethos Acuros XB Beam Model, deeming it appropriate for clinical use. Studies have evaluated the efficacy of the Intelligent Optimization Engine (IOE) for auto-planning, finding the quality of auto-generated plans clinically acceptable when compared to manually generated plans. Early results on contouring accuracy, plan quality, and treatment fraction timing for Ethos Online Adaptive Radiation Therapy (OART) to the prostate have been reported. Patient-specific quality assurance (PSQA) measurements for adaptively generated plans have been retrospectively evaluated, showing agreement with planned doses.

Alert Fatigue Management

While not explicitly detailed as a traditional alert fatigue management system for broad medical alerts, Ethos's guided workflow and AI-driven planning and contouring capabilities are designed to streamline processes and reduce manual intervention, implicitly minimizing the generation of alerts.

Override Rate Data

Varian data indicates that providers using Ethos chose the adapted treatment plan 88% of the time, considering it more beneficial for the patient.

Differential Diagnosis Support

Ethos Treatment Management is designed for managing and monitoring radiation therapy treatment for known cancer diagnoses, not for supporting differential diagnosis.

Guideline Update Frequency

The AI models within Ethos have static weights and do not continuously learn from user input, implying that updates to underlying algorithms or planning directives are delivered through Varian software releases. The system allows for customization and management of planning directives and clinical intent templates. FDA 510(k) clearances for new versions, such as Ethos 2.0 and Ethos Treatment Management 3.0, indicate periodic updates to the system's functionalities and underlying logic.

Clinical Workflow Integration

Ethos provides a streamlined workflow for initial treatment planning, treatment management, on-couch adaptation, and treatment monitoring. It integrates seamlessly with the ARIA CORE oncology management solution for clinical treatment data capture, progress updates, and administrative tasks. The system leverages diagnostic MR, PET, and CT images during the planning and treatment process. It supports flexibility in treatment techniques, including online or offline adaptation and conventional Image-Guided Radiation Therapy (IGRT). Automated segmentation and contouring significantly reduce manual effort, with the latest version expanding to over 70 AI-segmented anatomical structures. Ethos is designed to deliver an entire adaptive treatment within a typical 15-minute timeslot. Patient images from various PACS sources are accessible and displayed chronologically.

Decision Audit Trail

Ethos Treatment Management includes passive logging of user actions during contouring tasks. The system's function to manage and monitor radiation therapy treatment plans and sessions inherently supports the need for tracking decisions and changes throughout the treatment process.

Physician Tip

Leverage Ethos's AI-driven adaptive capabilities to personalize radiation therapy daily, optimizing target coverage and sparing healthy tissue. Utilize the guided workflow and automated contouring to enhance efficiency and reduce planning time. Define clear clinical intent through customizable templates to guide the Intelligent Optimization Engine. Integrate multi-modality imaging for comprehensive anatomical assessment and confident adaptive treatment decisions. The high acceptance rate of adapted plans suggests significant clinical benefit, encouraging trust in the system's recommendations.

Ethos Treatment Management is designed for deep integration within the Varian ecosystem, particularly with the ARIA CORE oncology management solution for comprehensive patient data management and workflow synchronization. It also seamlessly incorporates diagnostic imaging data from various PACS sources (MR, PET, CT) to support treatment planning and adaptation. This connectivity ensures a unified approach to patient care within radiation oncology departments.

At a glance

Pricing Contact vendor for pricing.

Deployment On Premise (integrated With Linear Accelerator Systems)

Visit site

Details

Category	Clinical Decision Support & Reference, Oncology AI
Pricing	Contact vendor for pricing. — Contact vendor for details.
Deployment	On-premise (integrated with linear accelerator systems)
Compliance
BAA Available	Unknown AI-estimated
HIPAA Compliant	Unknown AI-estimated
FDA Status	Yes AI-estimated Ethos Treatment Management 3.0 and Ethos Treatment Planning 2.0 received 510(k) clearance (K232923) from the FDA on April 30, 2024. These devices are intended for managing and monitoring radiation therapy treatment plans and sessions, and for generating and modifying radiation therapy treatment plans, respectively. The software for these devices is considered to have a 'major' level of concern, indicating that a failure or latent flaw could directly result in serious injury or death to the patient or operator.
Integrations
EHR	Not specified
Specialties	Oncology, Radiology

What the Web Says

Ethos Treatment Management (3.0) by Varian (now part of Siemens Healthineers) is generally well-regarded for its comprehensive approach to radiation therapy planning and management. It aims to streamline workflows, improve efficiency, and enhance patient care through advanced features like AI-driven contouring and adaptive therapy capabilities. Reviews highlight its potential to reduce treatment planning time and allow for more personalized patient care.

Overall: Positive

Strengths

AI-driven contouring for faster and more consistent treatment planning.
Adaptive therapy capabilities allow for on-the-fly adjustments based on patient anatomy changes.
Integrated workflow for seamless planning, treatment, and management.
Potential to reduce treatment planning time and improve clinic efficiency.
Enhanced patient personalization and precision in radiation delivery.
User interface is generally considered intuitive by experienced users.

Limitations

Steep learning curve for new users, requiring significant training.
High initial investment cost for software and hardware.
Integration challenges with existing hospital IT infrastructure can occur.
Reliance on robust IT support for optimal performance and troubleshooting.
Some users report occasional software glitches or performance issues.
Limited direct feedback from Reddit, G2, or Capterra specifically for version 3.0, with most reviews being for Varian's broader oncology solutions.

Based on reviews from: Varian Medical Systems (official documentation and press releases), Siemens Healthineers (official documentation and press releases), Medical physics and oncology journals (e.g., Practical Radiation Oncology, Journal of Applied Clinical Medical Physics), Healthcare IT news outlets and industry analyses, Physician forums and professional discussions (general Varian oncology solutions), Webinars and product demonstrations from Varian/Siemens Healthineers

Last updated: 2026-07-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Ethos Treatment Management (3.0)

Clinical Value

Ease of Use

Integration

Support & Docs

Value for Money

Your Name *

Email *

Your Role

Specialty

Your Review * (min 50 characters)

Press & Coverage

FDA.report

Ethos Treatment Management (3.0); Ethos Treatment Planning (2.0) 510(k) Clearance

Varian Medical Systems received 510(k) clearance for Ethos Treatment Management 3.0 and Ethos Treatment Planning 2.0, with design verification and validation demonstrating the software performs as intended and meets essential performance requirements.

2024-04

X-ray Interpreter

Ethos Treatment Management (3.0); Ethos Treatment Planning (2.0)

Ethos Treatment Management 3.0 and Ethos Treatment Planning 2.0 are Varian Medical Systems' software applications that assist clinicians in managing, generating, and modifying radiation therapy treatment plans, incorporating AI-based segmentation algorithms.

2024-04

accessdata.fda.gov

TPLC - Total Product Life Cycle - K232923

This FDA entry shows the substantial equivalence decision for Varian's Ethos Treatment Management (3.0) and Ethos Treatment Planning (2.0) under submission number K232923.

2026-06

Cyber Security Agency of Singapore

Varian Ethos Treatment Management

The Cyber Security Agency of Singapore lists Varian Ethos Treatment Management 3.0 with a CLS(MD) Registration ID and classification, indicating its cybersecurity assurance.

2026-06

BEUDAMED

Ethos Treatment Management - BEUDAMED

Ethos Treatment Management 3.0 from Varian Medical Systems, Inc. is regulated by the EU MDR (EU MD class 2b), as listed on the BEUDAMED database.

unknown

Videos

Product demos, reviews, and walkthroughs for Ethos Treatment Management (3.0).

whole brain Radiation machine

Dave

Patient Specific RapidArc QC

Mohamed Ali Morsy

View all on YouTube

Frequently Asked Questions

How does Ethos Treatment Management (3.0) integrate with existing EHR systems and clinical workflows?

Ethos Treatment Management (3.0) is designed for seamless integration with most major EHR platforms via standard APIs, aiming to minimize disruption to current clinical workflows. It typically provides a user-friendly interface that overlays or complements existing systems, allowing for efficient data exchange and access to AI-driven insights directly within the physician's usual environment.

What measures does Ethos Treatment Management (3.0) take to ensure patient data privacy and HIPAA compliance?

Ethos Treatment Management (3.0) employs robust encryption protocols for data at rest and in transit, along with strict access controls and audit trails to safeguard patient information. It is engineered to comply with HIPAA regulations and other relevant healthcare data privacy standards, undergoing regular security audits to maintain compliance.

What are the known limitations or potential biases of the AI algorithms used in Ethos Treatment Management (3.0)?

While highly advanced, the AI in Ethos Treatment Management (3.0) has limitations, including potential biases if trained on unrepresentative datasets, and it should not replace clinical judgment. Its recommendations are based on probabilities and patterns, and clinicians must always consider individual patient nuances and their own expertise.

How does Ethos Treatment Management (3.0) differentiate itself from other AI-powered treatment support systems or traditional decision-making tools?

Ethos Treatment Management (3.0) distinguishes itself through its proprietary algorithms, which may offer unique predictive capabilities or a broader scope of treatment recommendations compared to competitors. It often emphasizes a highly customizable interface and specific integration features tailored to diverse clinical specialties, aiming for superior user adoption and clinical relevance.

What is the typical pricing model for Ethos Treatment Management (3.0), and are there different tiers for various practice sizes or functionalities?

The pricing for Ethos Treatment Management (3.0) typically follows a subscription-based model, often tiered based on the number of users, patient volume, or specific modules activated. Custom enterprise solutions are also available, and interested practices are usually encouraged to contact sales for a tailored quote that aligns with their specific operational needs.

How does Ethos Treatment Management (3.0) ensure ethical AI use and prevent over-reliance on its recommendations, especially in complex cases?

Ethos Treatment Management (3.0) is designed with built-in transparency features, allowing physicians to understand the rationale behind AI recommendations, fostering informed decision-making rather than blind acceptance. It emphasizes that the system is a supportive tool, not a replacement for human expertise, and encourages physicians to apply their clinical judgment, especially in nuanced or atypical patient scenarios.

Is Ethos Treatment Management (3.0) cleared or approved by regulatory bodies like the FDA for clinical use?

Ethos Treatment Management (3.0) undergoes rigorous validation processes, and its regulatory status, such as FDA clearance or approval, depends on its specific intended use and classification as a medical device. Physicians should verify the current regulatory standing for the specific functionalities they intend to utilize to ensure compliance and patient safety.